| Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures Y Şenbabaoğlu, RS Gejman, AG Winer, M Liu, EM Van Allen, ... Genome biology 17, 1-25, 2016 | 779 | 2016 |
| Genome sequencing identifies a basis for everolimus sensitivity G Iyer, AJ Hanrahan, MI Milowsky, H Al-Ahmadie, SN Scott, ... Science 338 (6104), 221-221, 2012 | 719 | 2012 |
| Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma EM Van Allen, KW Mouw, P Kim, G Iyer, N Wagle, H Al-Ahmadie, C Zhu, ... Cancer discovery 4 (10), 1140-1153, 2014 | 579 | 2014 |
| Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1/PD-L1 blockade in advanced urothelial cancers MY Teo, K Seier, I Ostrovnaya, AM Regazzi, BE Kania, MM Moran, ... Journal of Clinical Oncology 36 (17), 1685, 2018 | 452 | 2018 |
| Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network AA Hakimi, I Ostrovnaya, B Reva, N Schultz, YB Chen, M Gonen, H Liu, ... Clinical Cancer Research 19 (12), 3259-3267, 2013 | 377 | 2013 |
| Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer G Iyer, H Al-Ahmadie, N Schultz, AJ Hanrahan, I Ostrovnaya, AV Balar, ... Journal of Clinical Oncology 31 (25), 3133, 2013 | 328 | 2013 |
| Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets EJ Pietzak, A Bagrodia, EK Cha, EN Drill, G Iyer, S Isharwal, I Ostrovnaya, ... European urology 72 (6), 952-959, 2017 | 309 | 2017 |
| Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations CA Karlo, PL Di Paolo, J Chaim, AA Hakimi, I Ostrovnaya, P Russo, ... Radiology 270 (2), 464-471, 2014 | 280 | 2014 |
| Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma … NKV Cheung, IY Cheung, BH Kushner, I Ostrovnaya, E Chamberlain, ... Journal of clinical oncology 30 (26), 3264, 2012 | 275 | 2012 |
| DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma MY Teo, RM Bambury, EC Zabor, E Jordan, H Al-Ahmadie, ME Boyd, ... Clinical cancer research 23 (14), 3610-3618, 2017 | 244 | 2017 |
| Genomic characterization of upper tract urothelial carcinoma JP Sfakianos, EK Cha, G Iyer, SN Scott, EC Zabor, RH Shah, Q Ren, ... European urology 68 (6), 970-977, 2015 | 236 | 2015 |
| Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma F Audenet, S Isharwal, EK Cha, MTA Donoghue, EN Drill, I Ostrovnaya, ... Clinical Cancer Research 25 (3), 967-976, 2019 | 195 | 2019 |
| Transcriptomic profiling of the tumor microenvironment reveals distinct subgroups of clear cell renal cell cancer: data from a randomized phase III trial AA Hakimi, MH Voss, F Kuo, A Sanchez, M Liu, BG Nixon, L Vuong, ... Cancer discovery 9 (4), 510-525, 2019 | 192 | 2019 |
| Phase II study of everolimus in metastatic urothelial cancer MI Milowsky, G Iyer, AM Regazzi, H Al-Ahmadie, SR Gerst, I Ostrovnaya, ... BJU international 112 (4), 462, 2013 | 186 | 2013 |
| Genomic and mutational profiling to assess clonal relationships between multiple non–small cell lung cancers N Girard, I Ostrovnaya, C Lau, B Park, M Ladanyi, D Finley, C Deshpande, ... Clinical cancer research 15 (16), 5184-5190, 2009 | 181 | 2009 |
| Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer HA Al-Ahmadie, G Iyer, BH Lee, SN Scott, R Mehra, A Bagrodia, ... Nature genetics 48 (4), 356-358, 2016 | 179 | 2016 |
| Gene-environment interaction effects on the development of immune responses in the 1st year of life S Hoffjan, D Nicolae, I Ostrovnaya, K Roberg, M Evans, DB Mirel, ... The American Journal of Human Genetics 76 (4), 696-704, 2005 | 166 | 2005 |
| Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder PH Kim, EK Cha, JP Sfakianos, G Iyer, EC Zabor, SN Scott, I Ostrovnaya, ... European urology 67 (2), 198-201, 2015 | 163 | 2015 |
| Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma V Tchekmedyian, EJ Sherman, L Dunn, C Tran, S Baxi, N Katabi, ... Journal of Clinical Oncology 37 (18), 1529, 2019 | 162 | 2019 |
| Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors A Bagrodia, BH Lee, W Lee, EK Cha, JP Sfakianos, G Iyer, EJ Pietzak, ... Journal of Clinical Oncology 34 (33), 4000, 2016 | 160 | 2016 |
